<?xml version="1.0" standalone="yes"?>
<REMINDER_EXCHANGE_FILE_ENTRY>
<PACKAGE_VERSION>2.0P65</PACKAGE_VERSION>
<INDEX_AT>634</INDEX_AT>
<SOURCE>
<NAME>UPDATE_2_0_446A VA-BENZODIAZEPINE/OPIOID ORDER CHECKS UPDATE</NAME>
<USER>PACKER,REMINDER</USER>
<SITE>FOIA</SITE>
<ENV>NATREM^NATREM^oitausdhctlexb.r02.domain.ext^NATREM:LEXR0TSVR</ENV>
<DATE_PACKED>02/05/2026@08:00:22</DATE_PACKED>
</SOURCE>
<DESCRIPTION><![CDATA[
The following Clinical Reminder items were selected for packing:
REMINDER ORDER CHECK ITEMS GROUP
  VA-BENZODIAZEPINE DRUG CLASS (CN302) (GROUP)
  VA-OPIOID DRUG CLASS (CN101) (GROUP)
 
REMINDER TERM
  VA-REMINDER UPDATE_2_0_446A
]]></DESCRIPTION>
<KEYWORDS>
</KEYWORDS>
<PACKING ATTRIBUTES><![CDATA[
<ATTRIBUTE>GROUPING DIALOG COMPONENTS</ATTRIBUTE>
]]></PACKING ATTRIBUTES>
<FILEMAN_FILE>
<FILE_NAME>VA DRUG CLASS</FILE_NAME>
<FILE_NUMBER>50.605</FILE_NUMBER>
<POINT_01>CN302</POINT_01>
<INTERNAL_ENTRY_NUMBER>83</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1229149839</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
50.605;+83,;.01~CN302
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>VA DRUG CLASS</FILE_NAME>
<FILE_NUMBER>50.605</FILE_NUMBER>
<POINT_01>CN101</POINT_01>
<INTERNAL_ENTRY_NUMBER>73</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3553547099</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
50.605;+73,;.01~CN101
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-REMINDER UPDATES [C]</POINT_01>
<INTERNAL_ENTRY_NUMBER>8722</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>981639263</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+8722,;.01~VA-REMINDER UPDATES [C]
9999999.64;+8722,;.1~CATEGORY
9999999.64;+8722,;100~LOCAL
9999999.64;+8722,;200~Reminder Updates
]]>
</FILEMAN_FDA>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>HEALTH FACTORS</FILE_NAME>
<FILE_NUMBER>9999999.64</FILE_NUMBER>
<POINT_01>VA-UPDATE_2_0_446A</POINT_01>
<INTERNAL_ENTRY_NUMBER>45726</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>841752398</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
9999999.64;+45726,;.01~VA-UPDATE_2_0_446A
9999999.64;+45726,;.03~VA-REMINDER UPDATES [C]
9999999.64;+45726,;.08~YES
9999999.64;+45726,;.1~FACTOR
9999999.64;+45726,;100~NATIONAL
9999999.64;+45726,;200~Update_2_0_446A
9999999.64;+45726,;201~WP-start~1
VA-UPDATE_2_0_446A
9999999.65;+45727,+45726,;.01~FEB 05, 2026@06:05:48
9999999.65;+45727,+45726,;2~WP-start~1
Copied from VA-UPDATE_2_0_446
9999999.65;+45728,+45726,;.01~FEB 05, 2026@06:06:02
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
45727^1
45728^2
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM)</POINT_01>
<INTERNAL_ENTRY_NUMBER>1514</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2876115637</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+1514,;.01~VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM)
811.5;+1514,;1~WP-start~2
R. Silverman 12-17-15 UPDATE_2_0_11
Updated 2023 to update status list - EG
811.5;+1514,;100~NATIONAL
811.52;+1515,+1514,;.01~DC.CN302
811.52;+1515,+1514,;15~NO
811.52;+1515,+1514,;18~YES
811.53;+1516,+1514,;.01~02/05/2026@08:00:30
811.53;+1516,+1514,;2~WP-start~1
Exchange Stub
811.54;+1517,+1515,+1514,;.01~ACTIVE
811.54;+1518,+1515,+1514,;.01~DISCONTINUED
811.54;+1519,+1515,+1514,;.01~DISCONTINUED (EDIT)
811.54;+1520,+1515,+1514,;.01~DISCONTINUED (RENEWAL)
811.54;+1521,+1515,+1514,;.01~EXPIRED
811.54;+1522,+1515,+1514,;.01~SUSPENDED
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
1515^1
1516^1
1517^1
1518^2
1519^3
1520^4
1521^5
1522^6
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM) NON-VA</POINT_01>
<INTERNAL_ENTRY_NUMBER>2919</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3416465854</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+2919,;.01~VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM) NON-VA
811.5;+2919,;100~NATIONAL
811.52;+2920,+2919,;.01~DC.CN302
811.52;+2920,+2919,;15~NO
811.52;+2920,+2919,;16~N
811.52;+2920,+2919,;18~YES
811.53;+2921,+2919,;.01~02/05/2026@08:00:30
811.53;+2921,+2919,;2~WP-start~1
Exchange Stub
811.54;+2922,+2920,+2919,;.01~ACTIVE
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
2920^1
2921^1
2922^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-OPIOID DRUG CLASS (CN101) (TERM) NON-VA</POINT_01>
<INTERNAL_ENTRY_NUMBER>2920</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2694809578</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+2920,;.01~VA-OPIOID DRUG CLASS (CN101) (TERM) NON-VA
811.5;+2920,;100~NATIONAL
811.52;+2921,+2920,;.01~DC.CN101
811.52;+2921,+2920,;15~NO
811.52;+2921,+2920,;16~N
811.52;+2921,+2920,;18~YES
811.53;+2922,+2920,;.01~02/05/2026@08:00:30
811.53;+2922,+2920,;2~WP-start~1
Exchange Stub
811.54;+2923,+2921,+2920,;.01~ACTIVE
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
2921^1
2922^1
2923^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-OPIOID DRUG CLASS (CN101) (TERM)</POINT_01>
<INTERNAL_ENTRY_NUMBER>1513</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2839674990</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+1513,;.01~VA-OPIOID DRUG CLASS (CN101) (TERM)
811.5;+1513,;1~WP-start~2
R. Silverman 12-17-15 UPDATE_2_0_11
Updated 2023 to update status list - EG
811.5;+1513,;100~NATIONAL
811.52;+1514,+1513,;.01~DC.CN101
811.52;+1514,+1513,;15~NO
811.52;+1514,+1513,;18~YES
811.53;+1515,+1513,;.01~02/05/2026@08:00:30
811.53;+1515,+1513,;2~WP-start~1
Exchange Stub
811.54;+1516,+1514,+1513,;.01~ACTIVE
811.54;+1517,+1514,+1513,;.01~DISCONTINUED
811.54;+1518,+1514,+1513,;.01~DISCONTINUED (EDIT)
811.54;+1519,+1514,+1513,;.01~DISCONTINUED (RENEWAL)
811.54;+1520,+1514,+1513,;.01~EXPIRED
811.54;+1521,+1514,+1513,;.01~SUSPENDED
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
1514^1
1515^1
1516^1
1517^2
1518^3
1519^4
1520^5
1521^6
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER TERM</FILE_NAME>
<FILE_NUMBER>811.5</FILE_NUMBER>
<POINT_01>VA-REMINDER UPDATE_2_0_446A</POINT_01>
<INTERNAL_ENTRY_NUMBER>3474</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>1438785791</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.5;+3474,;.01~VA-REMINDER UPDATE_2_0_446A
811.5;+3474,;100~NATIONAL
811.52;+3475,+3474,;.01~HF.VA-UPDATE_2_0_446A
811.52;+3475,+3474,;11~0
811.52;+3475,+3474,;15~NO
811.53;+3476,+3474,;.01~02/05/2026@08:00:30
811.53;+3476,+3474,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
3475^2
3476^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DEFINITION</FILE_NAME>
<FILE_NUMBER>811.9</FILE_NUMBER>
<POINT_01>VA-BENZODIAZEPINE (CN302)</POINT_01>
<INTERNAL_ENTRY_NUMBER>704</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>26218075</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.9;+704,;.01~VA-BENZODIAZEPINE (CN302)
811.9;+704,;2~WP-start~2
This reminder will show due now if the patient has a current NON VA 
banzodiazepine prescription or a VA prescription within the past 180 days.
811.9;+704,;30~FI(1)!FI(2)
811.9;+704,;31~FI(1)!FI(2)
811.9;+704,;32~2
811.9;+704,;33~1;2
811.9;+704,;36~0
811.9;+704,;40~0
811.9;+704,;42~0
811.9;+704,;62~0
811.9;+704,;63~0
811.9;+704,;67~0
811.9;+704,;68~0
811.9;+704,;72~0
811.9;+704,;73~0
811.9;+704,;77~0
811.9;+704,;78~0
811.9;+704,;85~0
811.9;+704,;86~0
811.9;+704,;95~0
811.9;+704,;96~0
811.9;+704,;100~NATIONAL
811.9;+704,;103~O
811.9001;+705,+704,;.01~02/05/2026@08:00:30
811.9001;+705,+704,;2~WP-start~1
Exchange Stub
811.902;+706,+704,;.01~RT.VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM) NON-VA
811.902;+706,+704,;15~NO
811.902;+706,+704,;24~0
811.902;+706,+704,;25~0
811.902;+707,+704,;.01~RT.VA-BENZODIAZEPINE DRUG CLASS (CN302) (TERM)
811.902;+707,+704,;9~T-180D
811.902;+707,+704,;15~NO
811.902;+707,+704,;16~OI
811.902;+707,+704,;24~0
811.902;+707,+704,;25~0
811.90221;+708,+706,+704,;.01~ACTIVE
811.90221;+709,+707,+704,;.01~ACTIVE
811.90221;+710,+706,+704,;.01~DISCONTINUED
811.90221;+711,+707,+704,;.01~DISCONTINUED
811.90221;+712,+706,+704,;.01~DISCONTINUED (EDIT)
811.90221;+713,+707,+704,;.01~DISCONTINUED (EDIT)
811.90221;+714,+706,+704,;.01~DISCONTINUED (RENEWAL)
811.90221;+715,+707,+704,;.01~DISCONTINUED (RENEWAL)
811.90221;+716,+706,+704,;.01~EXPIRED
811.90221;+717,+707,+704,;.01~EXPIRED
811.90221;+718,+706,+704,;.01~SUSPENDED
811.90221;+719,+707,+704,;.01~SUSPENDED
811.97;+720,+704,;.01~99Y
811.97;+720,+704,;5~0
811.97;+720,+704,;6~0
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
705^1
706^1
707^2
708^1
709^1
710^2
711^2
712^3
713^3
714^4
715^4
716^5
717^5
718^6
719^6
720^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER DEFINITION</FILE_NAME>
<FILE_NUMBER>811.9</FILE_NUMBER>
<POINT_01>VA-OPIOID (CN101)</POINT_01>
<INTERNAL_ENTRY_NUMBER>703</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>2695727664</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
811.9;+703,;.01~VA-OPIOID (CN101)
811.9;+703,;2~WP-start~2
This reminder will show due now if the patient has a current NON VA 
Opioid prescription or a VA prescription within the past 180 days.
811.9;+703,;30~FI(1)!FI(4)
811.9;+703,;31~FI(1)!FI(4)
811.9;+703,;32~2
811.9;+703,;33~1;4
811.9;+703,;36~0
811.9;+703,;40~0
811.9;+703,;42~0
811.9;+703,;62~0
811.9;+703,;63~0
811.9;+703,;67~0
811.9;+703,;68~0
811.9;+703,;72~0
811.9;+703,;73~0
811.9;+703,;77~0
811.9;+703,;78~0
811.9;+703,;85~0
811.9;+703,;86~0
811.9;+703,;95~0
811.9;+703,;96~0
811.9;+703,;100~NATIONAL
811.9;+703,;103~O
811.9001;+704,+703,;.01~02/05/2026@08:00:30
811.9001;+704,+703,;2~WP-start~1
Exchange Stub
811.902;+705,+703,;.01~RT.VA-OPIOID DRUG CLASS (CN101) (TERM)
811.902;+705,+703,;8~AND
811.902;+705,+703,;9~T-180D
811.902;+705,+703,;15~NO
811.902;+705,+703,;16~OI
811.902;+705,+703,;24~0
811.902;+705,+703,;25~0
811.902;+706,+703,;.01~RT.VA-OPIOID DRUG CLASS (CN101) (TERM) NON-VA
811.902;+706,+703,;15~NO
811.902;+706,+703,;16~N
811.902;+706,+703,;24~0
811.902;+706,+703,;25~0
811.90221;+707,+705,+703,;.01~ACTIVE
811.90221;+708,+706,+703,;.01~ACTIVE
811.90221;+709,+705,+703,;.01~DISCONTINUED
811.90221;+710,+705,+703,;.01~DISCONTINUED (EDIT)
811.90221;+711,+705,+703,;.01~DISCONTINUED (RENEWAL)
811.90221;+712,+705,+703,;.01~EXPIRED
811.90221;+713,+705,+703,;.01~SUSPENDED
811.97;+714,+703,;.01~99Y
811.97;+714,+703,;5~0
811.97;+714,+703,;6~0
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
704^1
705^1
706^4
707^1
708^1
709^2
710^3
711^4
712^5
713^6
714^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER ORDER CHECK RULES</FILE_NAME>
<FILE_NUMBER>801.1</FILE_NUMBER>
<POINT_01>VA-BENZODIAZEPINE DRUG CLASS (CN302) (RULE)</POINT_01>
<INTERNAL_ENTRY_NUMBER>2</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3745697469</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.1;+2,;.01~VA-BENZODIAZEPINE DRUG CLASS (CN302) (RULE)
801.1;+2,;1~Potential dangerous drug combination with a BENZODIAZEPINE
801.1;+2,;2~PRODUCTION
801.1;+2,;4~HIGH
801.1;+2,;10~WP-start~3
Order check to inform providers of the potential dangerous interaction of 
prescribing an Opioid in combination with a Benzodiazepine. Tramadol 
added to CN101 and Clonazepam added to CN302.
801.1;+2,;30~VA-BENZODIAZEPINE (CN302)
801.1;+2,;31~APPLICABLE
801.1;+2,;32~ORDER CHECK TEXT ONLY
801.1;+2,;40~WP-start~21
ACTION: \\
1. Avoid initiating/consider alternatives to this combination.\\
For established patients on this combination, consider tapering (if\\
long-term, consider tapering one medication slowly). If proceeding 
with\\
combination, clinical justification is required.\\
 
2. Overdose Education and Naloxone Distribution (OEND): offering is\\ 
required. 
 
RATIONALE: Prescribing Opioids and Benzodiazepines concurrently has 
been\\ 
shown to have a 4-fold increased risk of overdose in the Veteran\\
population.  Review the Stratification Tool for Opioid Risk Mitigation\\
(STORM) for additional details:\\
https://cds.domain.ext/smart-container/storm?utm_source=crocs
 
The OVERDOSE EDUCATION AND NALOXONE progress note -OR- the OFFER OVERDOSE 
EDUCATION AND NALOXONE reminder may be used for documentation. OEND 
patient handouts are available at: \\
https://dvagov.sharepoint.com/sites/vhaacademicdetailing/SitePages/OEND.aspx#bh
801.1;+2,;45~21
801.1;+2,;46~19
801.1;+2,;47~WP-start~19
ACTION: 
1. Avoid initiating/consider alternatives to this combination.
For established patients on this combination, consider tapering (if
long-term, consider tapering one medication slowly). If proceeding with
combination, clinical justification is required.
 
2. Overdose Education and Naloxone Distribution (OEND): offering is
 required.
 
RATIONALE: Prescribing Opioids and Benzodiazepines concurrently has been
 shown to have a 4-fold increased risk of overdose in the Veteran
population.  Review the Stratification Tool for Opioid Risk Mitigation
(STORM) for additional details:
https://cds.domain.ext/smart-container/storm?utm_source=crocs
 
The OVERDOSE EDUCATION AND NALOXONE progress note -OR- the OFFER OVERDOSE
EDUCATION AND NALOXONE reminder may be used for documentation. OEND patient
handouts are available at: 
https://dvagov.sharepoint.com/sites/vhaacademicdetailing/SitePages/OEND.aspx#bh
801.1;+2,;100~NATIONAL
801.13;+3,+2,;.01~02/05/2026@08:00:30
801.13;+3,+2,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
3^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER ORDER CHECK RULES</FILE_NAME>
<FILE_NUMBER>801.1</FILE_NUMBER>
<POINT_01>VA-OPIOID DRUG CLASS (CN101) (RULE)</POINT_01>
<INTERNAL_ENTRY_NUMBER>1</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>801789175</CHECKSUM>
<SELECTED>NO</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801.1;+1,;.01~VA-OPIOID DRUG CLASS (CN101) (RULE)
801.1;+1,;1~Potential dangerous drug combination with an OPIOID
801.1;+1,;2~PRODUCTION
801.1;+1,;4~HIGH
801.1;+1,;10~WP-start~3
Order check to inform providers of the potential dangerous interaction of 
prescribing an Opioid in combination with a Benzodiazepine. Tramadol 
added to CN101 and Clonazepam added to CN302.
801.1;+1,;30~VA-OPIOID (CN101)
801.1;+1,;31~APPLICABLE
801.1;+1,;32~ORDER CHECK TEXT ONLY
801.1;+1,;40~WP-start~19
ACTION: \\
1. Avoid initiating/consider alternatives to this combination.\\
For established patients on this combination, consider tapering (if\\
long-term, consider tapering one medication slowly). If proceeding with\\
combination, clinical justification is required.\\
 
2. Overdose Education and Naloxone Distribution (OEND): offering is \\
required. 
 
RATIONALE: Prescribing Opioids and Benzodiazepines concurrently has been\\
shown to have a 4-fold increased risk of overdose in the Veteran\\
population.  Review the Stratification Tool for Opioid Risk Mitigation\\
(STORM) for additional details:\\
https://cds.domain.ext/smart-container/storm?utm_source=crocs
 
The OVERDOSE EDUCATION AND NALOXONE progress note -OR- the OFFER OVERDOSE 
EDUCATION AND NALOXONE reminder may be used for documentation. OEND 
patient handouts are available at:\\
https://dvagov.sharepoint.com/sites/vhaacademicdetailing/SitePages/OEND.aspx#bh
801.1;+1,;45~19
801.1;+1,;46~19
801.1;+1,;47~WP-start~19
ACTION: 
1. Avoid initiating/consider alternatives to this combination.
For established patients on this combination, consider tapering (if
long-term, consider tapering one medication slowly). If proceeding with
combination, clinical justification is required.
 
2. Overdose Education and Naloxone Distribution (OEND): offering is 
required.
 
RATIONALE: Prescribing Opioids and Benzodiazepines concurrently has been
shown to have a 4-fold increased risk of overdose in the Veteran
population.  Review the Stratification Tool for Opioid Risk Mitigation
(STORM) for additional details:
https://cds.domain.ext/smart-container/storm?utm_source=crocs
 
The OVERDOSE EDUCATION AND NALOXONE progress note -OR- the OFFER OVERDOSE
EDUCATION AND NALOXONE reminder may be used for documentation. OEND patient
handouts are available at:
https://dvagov.sharepoint.com/sites/vhaacademicdetailing/SitePages/OEND.aspx#bh
801.1;+1,;100~NATIONAL
801.13;+2,+1,;.01~02/05/2026@08:00:30
801.13;+2,+1,;2~WP-start~1
Exchange Stub
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
2^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER ORDER CHECK ITEMS GROUP</FILE_NAME>
<FILE_NUMBER>801</FILE_NUMBER>
<POINT_01>VA-OPIOID DRUG CLASS (CN101) (GROUP)</POINT_01>
<INTERNAL_ENTRY_NUMBER>3</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>624510266</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801;+3,;.01~VA-OPIOID DRUG CLASS (CN101) (GROUP)
801;+3,;10~WP-start~2
Order check to inform providers of the potential dangerous interaction of 
prescribing an Opioid in combination with a Benzodiazepine.
801;+3,;100~NATIONAL
801.015;+4,+3,;.01~DC.CN101
801.03;+5,+3,;.01~02/05/2026@08:00:30
801.03;+5,+3,;2~WP-start~1
Exchange Stub
801.04;+6,+3,;.01~VA-BENZODIAZEPINE DRUG CLASS (CN302) (RULE)
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
4^1
5^1
6^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<FILEMAN_FILE>
<FILE_NAME>REMINDER ORDER CHECK ITEMS GROUP</FILE_NAME>
<FILE_NUMBER>801</FILE_NUMBER>
<POINT_01>VA-BENZODIAZEPINE DRUG CLASS (CN302) (GROUP)</POINT_01>
<INTERNAL_ENTRY_NUMBER>2</INTERNAL_ENTRY_NUMBER>
<CHECKSUM>3711050267</CHECKSUM>
<SELECTED>YES</SELECTED>
<FILEMAN_FDA>
<![CDATA[
801;+2,;.01~VA-BENZODIAZEPINE DRUG CLASS (CN302) (GROUP)
801;+2,;10~WP-start~2
Order check to inform providers of the potential dangerous interaction of 
prescribing an Opioid in combination with a Benzodiazepine.
801;+2,;100~NATIONAL
801.015;+3,+2,;.01~DC.CN302
801.03;+4,+2,;.01~02/05/2026@08:00:30
801.03;+4,+2,;2~WP-start~1
Exchange Stub
801.04;+5,+2,;.01~VA-OPIOID DRUG CLASS (CN101) (RULE)
]]>
</FILEMAN_FDA>
<IEN_ROOT>
<![CDATA[
3^1
4^1
5^1
]]>
</IEN_ROOT>
</FILEMAN_FILE>
<INDEX>
<NUMBER_OF_COMPONENTS>15</NUMBER_OF_COMPONENTS>
<COMPONENT>
<FDA_END>35</FDA_END>
<FDA_START>35</FDA_START>
<FILE_START>26</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>48</FDA_END>
<FDA_START>48</FDA_START>
<FILE_START>39</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>64</FDA_END>
<FDA_START>61</FDA_START>
<FILE_START>52</FILE_START>
</COMPONENT>
<COMPONENT>
<FDA_END>88</FDA_END>
<FDA_START>77</FDA_START>
<FILE_START>68</FILE_START>
<IEN_ROOT_END>94</IEN_ROOT_END>
<IEN_ROOT_START>93</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>123</FDA_END>
<FDA_START>107</FDA_START>
<FILE_START>98</FILE_START>
<IEN_ROOT_END>135</IEN_ROOT_END>
<IEN_ROOT_START>128</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>157</FDA_END>
<FDA_START>148</FDA_START>
<FILE_START>139</FILE_START>
<IEN_ROOT_END>164</IEN_ROOT_END>
<IEN_ROOT_START>162</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>186</FDA_END>
<FDA_START>177</FDA_START>
<FILE_START>168</FILE_START>
<IEN_ROOT_END>193</IEN_ROOT_END>
<IEN_ROOT_START>191</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>222</FDA_END>
<FDA_START>206</FDA_START>
<FILE_START>197</FILE_START>
<IEN_ROOT_END>234</IEN_ROOT_END>
<IEN_ROOT_START>227</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>254</FDA_END>
<FDA_START>247</FDA_START>
<FILE_START>238</FILE_START>
<IEN_ROOT_END>260</IEN_ROOT_END>
<IEN_ROOT_START>259</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>325</FDA_END>
<FDA_START>273</FDA_START>
<FILE_START>264</FILE_START>
<IEN_ROOT_END>345</IEN_ROOT_END>
<IEN_ROOT_START>330</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>407</FDA_END>
<FDA_START>358</FDA_START>
<FILE_START>349</FILE_START>
<IEN_ROOT_END>422</IEN_ROOT_END>
<IEN_ROOT_START>412</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>493</FDA_END>
<FDA_START>435</FDA_START>
<FILE_START>426</FILE_START>
<IEN_ROOT_END>498</IEN_ROOT_END>
<IEN_ROOT_START>498</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>567</FDA_END>
<FDA_START>511</FDA_START>
<FILE_START>502</FILE_START>
<IEN_ROOT_END>572</IEN_ROOT_END>
<IEN_ROOT_START>572</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>594</FDA_END>
<FDA_START>585</FDA_START>
<FILE_START>576</FILE_START>
<IEN_ROOT_END>601</IEN_ROOT_END>
<IEN_ROOT_START>599</IEN_ROOT_START>
</COMPONENT>
<COMPONENT>
<FDA_END>623</FDA_END>
<FDA_START>614</FDA_START>
<FILE_START>605</FILE_START>
<IEN_ROOT_END>630</IEN_ROOT_END>
<IEN_ROOT_START>628</IEN_ROOT_START>
</COMPONENT>
</INDEX>
</REMINDER_EXCHANGE_FILE_ENTRY>
